Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway

Published:2019-01 Issue: Volume:109 Page:563-572
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lou Changjie,Lu Haibo,Ma Zhigang,Liu Chao,Zhang Yanqiao

Funder

National Natural Science Foundation of China

Heilongjiang Provincial Natural Science Foundation Youth Science Foundation of China

Heilongjiang of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Pancreatic adenocarcinoma;Ryan;N. Engl. J. Med.,2014

2. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study;Quaresma;Lancet,2015

3. Pancreatic cancer;Kamisawa;Lancet,2016

4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1987

5. Action of 2’,2’ -difluorodeoxycytidine on DNA synthesis;Huang;Cancer Res.,1991

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation;Cancer Gene Therapy;2024-07-24

2. Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer;Pharmaceuticals;2024-07-09

3. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches;Cancer Letters;2024-04

4. The molecular mechanisms of ginkgo (Ginkgo biloba) activity in signaling pathways: A comprehensive review;Phytomedicine;2024-04

5. Different combination therapies pertaining to pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3